A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066
NCT01250730
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
PF-02341066
DRUG:
PF-02341066
DRUG:
PF-02341066
Sponsor
Pfizer